NEWPORT NEWS, Va., Nov. 24, 2015 /PRNewswire/ -- DILON
Diagnostics and GE Healthcare are pleased to announce that they
have signed an agreement for DILON to distribute GE's Discovery
NM750b Molecular Breast Imaging system in select geographies across
the globe. The signing of this distribution agreement will
provide Dilon's experienced distribution network access to GE's
Discovery NM750b Molecular Breast Imaging system and is considered
an initial step in an ongoing exploration of ways to provide better
healthcare solutions for clinicians and their patients.
The Discovery NM750b breast imaging system, designed to provide
significant enhancement in lesion detectability, offers clinicians
an important tool for imaging of a broad range of patients,
including those with dense breast who may be at higher risk for
breast cancer. The power of functional imaging to see early changes
is a key factor in early detection in breast cancer.
"We are very pleased to associate with GE Healthcare, a world
leader in innovation, in the fight against breast cancer," says
Robert G. Moussa, DILON Diagnostics
Chairman and CEO. "This relationship will enable us to expand our
product portfolio and offer a complete spectrum of BSGI/MBI
solutions to better meet the needs of our customers."
"We are excited to make the Discovery NM750b breast imaging
system further available and to benefit from DILON's global and
solid network of sales representatives," says Nathan Hermony,
Nuclear Imaging global business manager for GE Healthcare. "GE
believes strongly in this advanced technology and the potential for
this type of imaging to improve breast cancer diagnosis. DILON
Diagnostics resources will bring further the education and
acceptance of Molecular Breast Imaging," he adds.
About DILON Diagnostics
DILON Diagnostics, a brand of
DILON Technologies, Inc., located in Newport News, Virginia, designs, manufactures
and commercializes innovative medical imaging solutions
worldwide. DILON's cornerstone product, the DILON Molecular
Imaging System, is a high-resolution, compact camera for imaging
small body parts, such as the breast, thyroid, parathyroid and
bone. The DILON Molecular Imaging System has been optimized to
perform Molecular Breast Imaging (MBI/BSGI) procedure that aids in
the effective management of suspicious and difficult-to-interpret
breast cases. For more information on DILON Diagnostics please
visit www.dilon.com
About GE Healthcare
GE Healthcare provides
transformational medical technologies and services to meet the
demand for increased access, enhanced quality and more affordable
healthcare around the world. GE (NYSE: GE) works on things that
matter - great people and technologies taking on tough challenges.
From medical imaging, software & IT, patient monitoring and
diagnostics to drug discovery, biopharmaceutical manufacturing
technologies and performance improvement solutions, GE Healthcare
helps medical professionals deliver great healthcare to their
patients. For more information visit our
website www.gehealthcare.com
Media contact: Pjerin Luli
P: 757-269-4910
E: pluli@dilon.com
Logo -
http://photos.prnewswire.com/prnh/20140106/PH40697LOGO
Logo - http://photos.prnewswire.com/prnh/20151124/290662LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/dilon-diagnostics-and-ge-healthcare-announce-a-global-distribution-agreement-for-the-discovery-nm750b-molecular-breast-imaging-system-300184022.html
SOURCE Dilon Technologies, Inc.